Background: Preterm infants≤ 32 weeks' gestation are increasingly being managed on
continuous positive airway pressure (CPAP), without prior intubation and surfactant therapy …

Introduction Delivery room management using early nasal continuous positive airway
pressure (nCPAP) may delay surfactant therapy. Objective To identify factors associated with …

METHODS: Data from inborn preterm infants managed on CPAP from the outset were
analyzed in 2 gestational age ranges (25–28 and 29–32 completed weeks). Outcomes after …

Objective. Although earlier studies have suggested that early continuous airway positive
pressure (CPAP) may be beneficial in reducing ventilator dependence and subsequent …

This article explores the potential benefits and risks for the various approaches to the initial
respiratory management of preterm infants. The authors focus on the evidence for the …

Objectives: To document the effects of changing to a primarily nasal continuous positive
airway pressure (CPAP)‐based system of respiratory support on respiratory and non …

Abstract Context Continuous Positive Airway Pressure (CPAP) is a cost-effective and
minimal invasive respiratory support for the newborn. Objective To review the evidence …

Objective To evaluate the clinical course, respiratory outcomes and markers of inflammation
in preterm infants with moderate respiratory distress syndrome (RDS) assigned from birth to …

Background Continuous positive airway pressure (CPAP) is used widely to provide
respiratory support for neonates, and is often the first treatment choice in tertiary centres …

Objective To compare changes in lung volumes, as measured by functional residual
capacity (FRC), through to discharge in stable infants randomized to 2 weeks of extended …